Design, synthesis and biological evaluation of novel hamamelitannin analogues as potentiators for vancomycin in the treatment of biofilm related Staphylococcus aureus infections
- 1 October 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (19) , 4563-4575
Abstract
No abstract availableKeywords
Funding Information
- Research Fund Flanders
This publication has 13 references indexed in Scilit:
- The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA ReleaseScientific Reports, 2016
- Antibacterial drug discovery in the resistance eraNature, 2016
- Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and ManagementClinical Microbiology Reviews, 2015
- Quorum Sensing Inhibitors Increase the Susceptibility of Bacterial Biofilms to Antibiotics In Vitro and In VivoAntimicrobial Agents and Chemotherapy, 2011
- BiofilmsCold Spring Harbor Perspectives in Biology, 2010
- Carbon-branched δ-tetrahydrofuran sugar amino acids (SAAs) as dipeptide isostere scaffoldsTetrahedron: Asymmetry, 2008
- A Concise, Efficient and Production-Scale Synthesis of a Protected l-Lyxonolactone Derivative: An Important Aldonolactone CoreOrganic Process Research & Development, 2006
- Understanding biofilm resistance to antibacterial agentsNature Reviews Drug Discovery, 2003
- Staphylococcus aureusInfectionsNew England Journal of Medicine, 1998
- How Bacteria StickScientific American, 1978